-
Views
-
Cite
Cite
I. Navarro‐Navarro, D. Jiménez‐Gallo, S. Valenzuela‐Ubiña, M. Domínguez‐Gomez, M. Linares‐Barrios, Infantile bullous pemphigoid following serogroup B meningococcal vaccination, British Journal of Dermatology, Volume 184, Issue 3, 1 March 2021, Page e53, https://doi.org/10.1111/bjd.19480
- Share Icon Share
Extract
Funding sources: none.
Conflicts of interest: The authors declare they have no conflicts of interest.
...
Dear Editor, A 5‐month‐old male infant presented with bullous palmoplantar lesions. He had received serogroup B meningococcal vaccination 1 week previously. Physical examination showed tense palmoplantar blisters over an erythematoedematous base (a, b). Direct immunofluorescence showed a linear deposit of IgG and C3 on the basal lamina (c). The patient was diagnosed with infantile bullous pemphigoid (IBP). IBP is an infrequent variant of this blistering disease, which usually affects acral areas. Overall, the disease outcome is favourable.1 Cases of IBP following vaccination have been previously described.2 This is, to our knowledge, the first reported case of IBP following serogroup B meningococcal vaccination.
Author Contribution
Irene Navarro‐Navarro: Conceptualization (lead); Investigation (lead); Methodology (lead); Writing‐original draft (lead); Writing‐review & editing (lead). David Jiménez Gallo: Conceptualization (lead); Formal analysis (lead); Supervision (lead); Visualization (lead). Sandra Valenzuela Ubiña: Investigation (equal); Supervision (equal); Visualization (equal); Writing‐original draft (equal). Manuel Domínguez Gómez: Investigation (equal); Resources (equal); Visualization (equal). Mario Linares Barrios: Formal analysis (equal); Project administration (equal); Supervision (lead); Validation (lead); Visualization (lead).